The growth of bacteria in intravenous glyceryl trinitrate and in sodium nitroprusside.
Bátai
I
I
Department of Anaesthesia, Royal Liverpool University Hospital, United Kingdom.
Kerényi
M
M
Tekeres
M
M
D000959:Antihypertensive Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects* / Q000254:growth & development; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development; D006131:Growth Inhibitors / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D020030:Nitric Oxide Donors / Q000494:pharmacology*; D005996:Nitroglycerin / Q000494:pharmacology*; D009599:Nitroprusside / Q000494:pharmacology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000254:growth & development; D013211:Staphylococcus aureus / Q000187:drug effects / Q000254:growth & development; D013696:Temperature; D014665:Vasodilator Agents / Q000494:pharmacology
D000959:Antihypertensive Agents; D006131:Growth Inhibitors; D020030:Nitric Oxide Donors; D014665:Vasodilator Agents; D009599:Nitroprusside; D005996:Nitroglycerin